VANCOUVER – Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ), a plant-based extraction company focused on cannabis, hemp, functional mushrooms and the rapidly emerging psychedelic sector, reported that its wholly owned subsidiary, Pure Mushrooms Corp., has opened its online, direct-to-consumer, e-Commerce store on the Amazon platform and is selling its Reishi and Maitake formulations.
Pure Extracts CEO, Ben Nikolaevsky, remarked, “We are excited to be on Amazon, the largest online marketplace and the most powerful platform in the world for brand development, and to have made our first US and Canadian sales of our Pure Mushrooms products. The functional mushroom wellness market is experiencing robust sales as many consumers are trying to boost their immune systems in light of the COVID-19 pandemic. As we build-out the mushroom extraction section of our facility, we plan to bring more products to market.”
Pure Mushrooms formulations come in convenient gluten free vegan capsules and in addition to the Reishi and Maitake products currently available at US $19.97 for 90 capsule bottles, a Lion’s Mane formulation is expected to commence sales this summer. Given the dramatic rise in consumer demand for functional mushroom wellness products, Pure Mushrooms is expected to be a significant contributor the Company’s revenue growth in 2022.
Reishi mushrooms have been a staple in Eastern medicine for centuries and provide antioxidants, support for the immune system, help to increase energy and resistance to stress, and are often used to strengthen the body and nourish the heart in Traditional Chinese Medicine. Maitake mushrooms are widely used in the Japanese and Chinese cultures in foods and as a supplement, with perceived benefits in combating stress, supporting the immune system, with high antioxidants that benefit the heart and the brain. Lion’s Mane is thought to boost cognitive health and power, provide memory support and enhance mental clarity.
Pure Extracts Technology Corp. features an all-new, state-of-the-art processing facility located just 20 minutes north of world-famous Whistler, British Columbia. The bespoke facility has been constructed to European Union GMP standards aiming towards export sales of products and formulations, including those currently restricted in Canada, into European jurisdictions where they are legally available. On September 25, 2020, Pure Extracts was granted its Standard Processing License by Health Canada under the Cannabis Act and the company’s stock began trading on the Canadian Securities Exchange (CSE) on November 5, 2020.
We seel Safe Harbor.